LETERMOVIR

LETERMOVIR was reported 3257 times

LETERMOVIR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SARS-COV-2 RNA 4 0.5000
1 LUNG DISEASE INFECTIVE EXACERBATION 10 0.3704
2 GASTRITIS HERPES 3 0.3333
3 CHROMOSOME BANDING ABNORMAL 1 0.2500
4 ENCEPHALITIS CYTOMEGALOVIRUS 75 0.1712
5 COAGULATION FACTOR LEVEL ABNORMAL 1 0.1667
6 RETINITIS VIRAL 16 0.1322
7 HCOV-OC43 INFECTION 4 0.1290
8 CYTOMEGALOVIRUS TEST NEGATIVE 1 0.1250
9 ANTI B ANTIBODY POSITIVE 1 0.1111
10 AUTOIMMUNE PANCYTOPENIA 10 0.1099
11 HEPATIC HYPERTROPHY 3 0.0938
12 ACUTE FLACCID MYELITIS 1 0.0833
13 QUADRANTANOPIA 10 0.0763
14 HUMAN HERPESVIRUS 6 VIRAEMIA 3 0.0750
15 ACUTE GRAFT VERSUS HOST DISEASE ORAL 2 0.0645
16 EPSTEIN-BARR VIRAEMIA 69 0.0622
17 GINGIVITIS ULCERATIVE 13 0.0605
18 CYTOMEGALOVIRUS INFECTION REACTIVATION 260 0.0588
19 FLUORIDE INCREASED 3 0.0566
20 ANTIVIRAL DRUG LEVEL ABOVE THERAPEUTIC 4 0.0533
21 OESOPHAGEAL MUCOSAL DISSECTION 2 0.0513
22 PARENTERAL NUTRITION 11 0.0476
23 ENGRAFT FAILURE 12 0.0418
24 BRONCHIAL ANASTOMOSIS COMPLICATION 1 0.0417
25 PNEUMATURIA 4 0.0417
26 CYSTITIS VIRAL 15 0.0392
27 HUMAN HERPESVIRUS 6 ENCEPHALITIS 11 0.0387
28 DONOR LEUKOCYTE INFUSION 1 0.0385
29 BLOOD BETA-D-GLUCAN POSITIVE 1 0.0385
30 HUMAN HERPESVIRUS 7 INFECTION 3 0.0380
31 GASTROINTESTINAL TRACT MUCOSAL PIGMENTATION 10 0.0368
32 SUPERINFECTION FUNGAL 3 0.0353
33 ADENOVIRAL CONJUNCTIVITIS 1 0.0345
34 GRAFT VERSUS HOST DISEASE ORAL 2 0.0312
35 CORYNEBACTERIUM SEPSIS 2 0.0303
36 GASTROINTESTINAL MUCORMYCOSIS 5 0.0299
37 PARVOVIRUS INFECTION 12 0.0297
38 ACUTE MYELOID LEUKAEMIA (IN REMISSION) 1 0.0294
39 RESPIRATORY SYNCYTIAL VIRUS BRONCHITIS 4 0.0294
40 BURKHOLDERIA CEPACIA COMPLEX SEPSIS 1 0.0286
41 PARVOVIRUS B19 TEST POSITIVE 2 0.0282
42 ADENOVIRUS REACTIVATION 4 0.0278
43 BK VIRUS INFECTION 90 0.0267
44 DISSEMINATED VARICELLA 1 0.0263
45 MYELOBLAST COUNT INCREASED 2 0.0260
46 ALLOGENIC STEM CELL TRANSPLANTATION 4 0.0253
47 CYTOMEGALOVIRUS TEST POSITIVE 44 0.0247
48 CHRONIC GRAFT VERSUS HOST DISEASE IN EYE 5 0.0246
49 CYTOMEGALOVIRUS SYNDROME 4 0.0242
50 HERPES SIMPLEX VIRAEMIA 3 0.0240
51 CYTOMEGALOVIRUS GASTROENTERITIS 5 0.0231
52 CYSTITIS HAEMORRHAGIC 92 0.0228
53 ALBUMIN URINE 1 0.0227
54 GASTROINTESTINAL MUCOSAL EXFOLIATION 3 0.0226
55 DRUG RESISTANCE MUTATION 4 0.0225
56 CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION 1 0.0222
57 GRAFT VERSUS HOST DISEASE IN EYE 5 0.0216
58 CYTOMEGALOVIRUS VIRAEMIA 96 0.0216
59 T-LYMPHOCYTE COUNT DECREASED 14 0.0205
60 ENGRAFTMENT SYNDROME 12 0.0203
61 CYTOMEGALOVIRUS ENTEROCOLITIS 15 0.0195
62 GRAFT VERSUS HOST DISEASE IN LUNG 9 0.0188
63 NEW ONSET REFRACTORY STATUS EPILEPTICUS 2 0.0182
64 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 24 0.0170
65 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 22 0.0167
66 CYTOMEGALOVIRUS GASTROINTESTINAL ULCER 1 0.0164
67 ROSEOLOVIRUS TEST POSITIVE 2 0.0164
68 GRAFT VERSUS HOST DISEASE IN SKIN 36 0.0163
69 STOMATOCOCCAL INFECTION 2 0.0161
70 CYTOMEGALOVIRUS GASTRITIS 4 0.0158
71 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 43 0.0155
72 GRAFT VERSUS HOST DISEASE IN LIVER 11 0.0154
73 GASTROINTESTINAL MUCOSAL DISORDER 10 0.0153
74 ALBUMIN GLOBULIN RATIO INCREASED 2 0.0146
75 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 31 0.0146
76 CYTOMEGALOVIRUS HEPATITIS 5 0.0141
77 BLOOD STEM CELL TRANSPLANT FAILURE 3 0.0140
78 CYTOMEGALOVIRUS COLITIS 32 0.0139
79 POSTURAL TREMOR 4 0.0137
80 ENTEROBACTER BACTERAEMIA 4 0.0132
81 PRIMARY ADRENAL INSUFFICIENCY 4 0.0131
82 CEREBRAL TOXOPLASMOSIS 12 0.0128
83 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 65 0.0128
84 HEPATIC VEIN OCCLUSION 2 0.0127
85 LABELLED DRUG-DRUG INTERACTION ISSUE 18 0.0124
86 CHRONIC GRAFT VERSUS HOST DISEASE ORAL 3 0.0122
87 LUNG TRANSPLANT REJECTION 8 0.0121
88 HYPERCREATINAEMIA 4 0.0121
89 DIFFUSE AXONAL INJURY 1 0.0120
90 APOPTOTIC COLONOPATHY 1 0.0120
91 INFECTIVE MYOSITIS 2 0.0120
92 CORYNEBACTERIUM BACTERAEMIA 1 0.0118
93 PNEUMOCYSTIS JIROVECII INFECTION 14 0.0117
94 BONE MARROW TRANSPLANT 22 0.0116
95 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 38 0.0115
96 VIRAL LOAD ABNORMAL 2 0.0114
97 CHIMERISM 1 0.0112
98 PARVOVIRUS B19 INFECTION 10 0.0112
99 ADENOVIRUS INFECTION 32 0.0110
100 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 4 0.0110
101 ADAMTS13 ACTIVITY ABNORMAL 1 0.0110
102 CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE 2 0.0105
103 BK POLYOMAVIRUS TEST POSITIVE 1 0.0104
104 CYTOMEGALOVIRUS INFECTION 173 0.0104
105 ACUTE GRAFT VERSUS HOST DISEASE 47 0.0103
106 PNEUMONIA CYTOMEGALOVIRAL 19 0.0098
107 COMPLICATIONS OF TRANSPLANTED LUNG 3 0.0098
108 RED BLOOD CELL TRANSFUSION 4 0.0098
109 GRAFT VERSUS HOST DISEASE 69 0.0096
110 TRANSPLANTATION COMPLICATION 4 0.0095
111 COMPLEMENT FACTOR ABNORMAL 1 0.0093
112 CATHETER SITE OEDEMA 1 0.0092
113 BONE MARROW TRANSPLANT REJECTION 2 0.0091
114 SYSTEMIC MYCOSIS 10 0.0086
115 PATHOGEN RESISTANCE 78 0.0085
116 VIRAL HAEMORRHAGIC CYSTITIS 6 0.0084
117 ACUTE MYELOID LEUKAEMIA RECURRENT 18 0.0084
118 COMPLICATIONS OF BONE MARROW TRANSPLANT 3 0.0083
119 PNEUMONIA PSEUDOMONAL 12 0.0078
120 PULMONARY MUCORMYCOSIS 4 0.0076
121 APLASTIC ANAEMIA 39 0.0075
122 TUMOUR ASSOCIATED FEVER 3 0.0073
123 BRONCHOSTENOSIS 4 0.0073
124 MUCORMYCOSIS 19 0.0073
125 NEPHROPATHY TOXIC 82 0.0073
126 STEM CELL TRANSPLANT 18 0.0072
127 BACTERIAL SEPSIS 23 0.0071
128 INTENTION TREMOR 4 0.0070
129 IDIOPATHIC PNEUMONIA SYNDROME 2 0.0067
130 POST INFLAMMATORY PIGMENTATION CHANGE 3 0.0066
131 ABDOMINAL WALL WOUND 1 0.0065
132 VIRAL LOAD INCREASED 25 0.0064
133 BACTERIAL TRANSLOCATION 2 0.0063
134 BLOOD PRESSURE ORTHOSTATIC 1 0.0063
135 COLITIS EROSIVE 1 0.0063
136 PRIMARY MYELOFIBROSIS 2 0.0062
137 BLOOD CHLORIDE ABNORMAL 1 0.0062
138 BLADDER CYST 1 0.0062
139 STENOTROPHOMONAS INFECTION 8 0.0059
140 ACUTE MYELOID LEUKAEMIA REFRACTORY 1 0.0058
141 CHRONIC GRAFT VERSUS HOST DISEASE IN LUNG 1 0.0058
142 ENCEPHALITIS VIRAL 7 0.0057
143 NUTRITIONAL CONDITION ABNORMAL 4 0.0057
144 FUSARIUM INFECTION 4 0.0057
145 FUNGAEMIA 9 0.0057
146 BRONCHIOLITIS OBLITERANS SYNDROME 1 0.0057
147 IDIOPATHIC INTERSTITIAL PNEUMONIA 2 0.0056
148 GENERALISED OEDEMA 70 0.0056
149 CYTOMEGALOVIRUS ENTERITIS 2 0.0056
150 GASTROENTERITIS ESCHERICHIA COLI 3 0.0055
151 VENOOCCLUSIVE LIVER DISEASE 27 0.0055
152 PLATELET TRANSFUSION 7 0.0054
153 ENTEROBACTER SEPSIS 2 0.0054
154 BLOOD ALKALINE PHOSPHATASE 1 0.0054
155 HUMAN HERPESVIRUS 6 INFECTION 10 0.0053
156 LUMBAR PUNCTURE 2 0.0053
157 KLEBSIELLA BACTERAEMIA 5 0.0053
158 INFECTION REACTIVATION 6 0.0052
159 VENOOCCLUSIVE DISEASE 13 0.0052
160 CATHETER SITE INDURATION 1 0.0052
161 ASPERGILLUS INFECTION 34 0.0052
162 ENTERAL NUTRITION 3 0.0052
163 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 13 0.0050
164 EMPYEMA 10 0.0050
165 HAEMOPERITONEUM 4 0.0050
166 MITOCHONDRIAL TOXICITY 4 0.0049
167 VARICELLA ZOSTER VIRUS INFECTION 10 0.0048
168 ADENOVIRAL HAEMORRHAGIC CYSTITIS 1 0.0048
169 OPTIC NEUROPATHY 10 0.0047
170 ENTEROCOCCAL BACTERAEMIA 5 0.0047
171 PSEUDOMONAL BACTERAEMIA 4 0.0047
172 COLONIC ABSCESS 4 0.0047
173 CYTOMEGALOVIRUS CHORIORETINITIS 9 0.0046
174 CHRONIC MYELOID LEUKAEMIA TRANSFORMATION 2 0.0045
175 BLOOD ALKALINE PHOSPHATASE ABNORMAL 4 0.0044
176 LICHENOID KERATOSIS 10 0.0044
177 BREAKTHROUGH COVID-19 1 0.0043
178 STRONGYLOIDIASIS 7 0.0043
179 CREATININE RENAL CLEARANCE ABNORMAL 2 0.0043
180 ADENOVIRAL HEPATITIS 1 0.0043
181 BRONCHOSCOPY 1 0.0042
182 NOROVIRUS INFECTION 6 0.0042
183 MUCOSAL DISORDER 4 0.0040
184 LEUKOENCEPHALOPATHY 15 0.0040
185 WEST NILE VIRAL INFECTION 3 0.0040
186 ACUTE MYELOMONOCYTIC LEUKAEMIA 1 0.0040
187 THROMBOTIC MICROANGIOPATHY 38 0.0039
188 DRUG RESISTANCE 99 0.0039
189 LUNG OPACITY 10 0.0038
190 POLYOMAVIRUS VIRAEMIA 4 0.0038
191 SINUSITIS FUNGAL 3 0.0037
192 HEART FAILURE WITH REDUCED EJECTION FRACTION 2 0.0037
193 IMMUNE THROMBOCYTOPENIA 17 0.0037
194 DISEASE SUSCEPTIBILITY 1 0.0036
195 CARDIAC SEPTAL HYPERTROPHY 1 0.0036
196 VIRAEMIA 5 0.0036
197 GASTROINTESTINAL TUBE INSERTION 9 0.0036
198 CHRONIC GRAFT VERSUS HOST DISEASE 13 0.0036
199 ANAEMIA OF MALIGNANT DISEASE 1 0.0036
200 MULTIPLE-DRUG RESISTANCE 11 0.0035
201 AUTOIMMUNE NEUTROPENIA 1 0.0035
202 CATHETER SITE CELLULITIS 1 0.0034
203 XEROPHTHALMIA 2 0.0034
204 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 4 0.0033
205 ASPERGILLUS TEST POSITIVE 1 0.0032
206 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 3 0.0032
207 APOPTOSIS 1 0.0032
208 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 1 0.0032
209 MONOCYTOSIS 2 0.0032
210 URINARY TRACT INFECTION ENTEROCOCCAL 3 0.0032
211 MICROANGIOPATHY 3 0.0032
212 BRAIN ABSCESS 8 0.0032
213 INHIBITORY DRUG INTERACTION 5 0.0032
214 GASTROINTESTINAL EROSION 2 0.0031
215 NOCARDIOSIS 8 0.0031
216 BLOOD BILIRUBIN ABNORMAL 4 0.0031
217 OESOPHAGITIS 34 0.0031
218 TELANGIECTASIA 3 0.0031
219 STAPHYLOCOCCAL SEPSIS 15 0.0030
220 BLAST CELL CRISIS 1 0.0030
221 KLEBSIELLA INFECTION 15 0.0030
222 CYSTITIS BACTERIAL 1 0.0030
223 TRANSPLANT 7 0.0029
224 LICHEN SCLEROSUS 2 0.0029
225 HERPES SIMPLEX 19 0.0029
226 RESPIRATORY DISTRESS 80 0.0029
227 ENTEROCOCCAL INFECTION 14 0.0029
228 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 2 0.0028
229 PHILADELPHIA CHROMOSOME POSITIVE 2 0.0027
230 PANCYTOPENIA 153 0.0027
231 DIFFERENTIATION SYNDROME 2 0.0027
232 CALCIPHYLAXIS 5 0.0027
233 CYTOMEGALOVIRUS OESOPHAGITIS 1 0.0027
234 DRUG LEVEL INCREASED 45 0.0027
235 BASOPHIL COUNT INCREASED 2 0.0026
236 ASPARTATE AMINOTRANSFERASE ABNORMAL 4 0.0026
237 METAPNEUMOVIRUS INFECTION 2 0.0026
238 ASYMPTOMATIC COVID-19 1 0.0025
239 CELL DEATH 5 0.0025
240 PERFORATION 2 0.0025
241 ENTEROCOCCAL SEPSIS 2 0.0025
242 CYTOPENIA 30 0.0024
243 TRANSPLANT FAILURE 6 0.0024
244 MYELOSUPPRESSION 88 0.0024
245 PULMONARY NOCARDIOSIS 2 0.0024
246 RENAL ATROPHY 3 0.0024
247 STARVATION 2 0.0024
248 BLOOD PRODUCT TRANSFUSION DEPENDENT 1 0.0024
249 CD4 LYMPHOCYTES DECREASED 5 0.0023
250 CITROBACTER INFECTION 1 0.0023
251 MUCOSAL INFLAMMATION 61 0.0023
252 BRONCHOPULMONARY ASPERGILLOSIS 18 0.0023
253 ENTEROVIRUS INFECTION 2 0.0023
254 BONE MARROW DISORDER 7 0.0023
255 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 14 0.0023
256 OBLITERATIVE BRONCHIOLITIS 3 0.0023
257 HYPOGAMMAGLOBULINAEMIA 15 0.0023
258 PNEUMONIA FUNGAL 9 0.0023
259 OESOPHAGEAL HAEMORRHAGE 3 0.0023
260 BLADDER HYPERTROPHY 1 0.0023
261 LYMPHOPENIA 32 0.0023
262 TRANSPLANT DYSFUNCTION 4 0.0022
263 CANDIDA SEPSIS 2 0.0022
264 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0022
265 CACHEXIA 11 0.0021
266 INTRACRANIAL MASS 2 0.0021
267 KIDNEY TRANSPLANT REJECTION 10 0.0021
268 BLAST CELLS PRESENT 1 0.0021
269 EPSTEIN-BARR VIRUS INFECTION 13 0.0021
270 GUILLAIN-BARRE SYNDROME 10 0.0021
271 BLINDNESS CORTICAL 1 0.0020
272 GENERALISED ANXIETY DISORDER 3 0.0020
273 HYPOFIBRINOGENAEMIA 2 0.0020
274 BLOOD IMMUNOGLOBULIN M DECREASED 2 0.0020
275 PARAINFLUENZAE VIRUS INFECTION 3 0.0020
276 CARDIAC FAILURE ACUTE 13 0.0019
277 PRODUCT BLISTER PACKAGING ISSUE 2 0.0019
278 BLOOD ALBUMIN ABNORMAL 1 0.0019
279 TRANSFUSION 20 0.0019
280 COGWHEEL RIGIDITY 2 0.0019
281 ALANINE AMINOTRANSFERASE ABNORMAL 4 0.0019
282 PNEUMOCYSTIS JIROVECII PNEUMONIA 19 0.0019
283 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 5 0.0019
284 BLOOD POTASSIUM ABNORMAL 5 0.0019
285 GASTROINTESTINAL TOXICITY 9 0.0019
286 CORYNEBACTERIUM INFECTION 1 0.0019
287 AUTOIMMUNE HEPATITIS 13 0.0019
288 BACTERAEMIA 22 0.0019
289 IRON OVERLOAD 2 0.0019
290 CRYPTOCOCCOSIS 3 0.0018
291 CRYSTALLURIA 1 0.0018
292 CHRONIC MYELOID LEUKAEMIA RECURRENT 1 0.0018
293 NEAR DEATH EXPERIENCE 6 0.0018
294 BLOOD INSULIN INCREASED 1 0.0018
295 CHOROIDAL DETACHMENT 1 0.0018
296 RHINOVIRUS INFECTION 7 0.0018
297 EROSIVE OESOPHAGITIS 3 0.0018
298 COLONIC FISTULA 1 0.0018
299 CELLULITIS ORBITAL 1 0.0017
300 PSEUDOMONAL SEPSIS 3 0.0017
301 ESCHERICHIA BACTERAEMIA 4 0.0017
302 ALVEOLAR PROTEINOSIS 1 0.0017
303 CRYSTAL NEPHROPATHY 1 0.0017
304 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 16 0.0017
305 HYPOALBUMINAEMIA 13 0.0017
306 ATYPICAL PNEUMONIA 5 0.0017
307 DRUG LEVEL DECREASED 17 0.0017
308 DYSPLASIA 2 0.0017
309 ACUTE MYELOID LEUKAEMIA 26 0.0017
310 PNEUMOMEDIASTINUM 3 0.0017
311 HAEMATOLOGICAL INFECTION 4 0.0016
312 DRUG LEVEL CHANGED 1 0.0016
313 IMMUNOSUPPRESSION 14 0.0016
314 PHYSICAL DECONDITIONING 4 0.0016
315 INTESTINAL DILATATION 2 0.0015
316 TRANSPLANT REJECTION 12 0.0015
317 LUNG DISORDER 73 0.0015
318 EMERGENCY CARE EXAMINATION 1 0.0015
319 GASTRIC PERFORATION 4 0.0015
320 MENINGITIS VIRAL 2 0.0015
321 ANGULAR CHEILITIS 1 0.0014
322 PROTHROMBIN TIME SHORTENED 2 0.0014
323 SEPTIC SHOCK 62 0.0014
324 NEUTROPHIL COUNT ABNORMAL 4 0.0014
325 ACUTE RESPIRATORY DISTRESS SYNDROME 25 0.0014
326 INTENSIVE CARE 2 0.0014
327 DELAYED GRAFT FUNCTION 1 0.0014
328 TRACHEOSTOMY 2 0.0014
329 RENAL TRANSPLANT 5 0.0014
330 ESCHERICHIA SEPSIS 4 0.0014
331 BLOOD BILIRUBIN UNCONJUGATED INCREASED 1 0.0014
332 MULTIPLE ORGAN DYSFUNCTION SYNDROME 39 0.0014
333 BACTERIAL DISEASE CARRIER 1 0.0014
334 VIRAL MUTATION IDENTIFIED 5 0.0014
335 GASTROINTESTINAL WALL THICKENING 2 0.0013
336 IRON DEFICIENCY 6 0.0013
337 COMPLICATIONS OF TRANSPLANTED KIDNEY 3 0.0013
338 DISSEMINATED CRYPTOCOCCOSIS 1 0.0013
339 CHEMOTHERAPY 5 0.0013
340 PALLIATIVE CARE 2 0.0013
341 PANCREATITIS NECROTISING 3 0.0013
342 PSEUDOMONAS INFECTION 11 0.0013
343 DIARRHOEA INFECTIOUS 1 0.0013
344 DRUG LEVEL BELOW THERAPEUTIC 7 0.0013
345 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 1 0.0012
346 AUTOIMMUNE DISORDER 12 0.0012
347 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
348 MEAN CELL HAEMOGLOBIN INCREASED 2 0.0012
349 CIRCADIAN RHYTHM SLEEP DISORDER 1 0.0012
350 FEBRILE NEUTROPENIA 80 0.0012
351 CAMPYLOBACTER INFECTION 1 0.0012
352 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 9 0.0012
353 SYSTEMIC CANDIDA 3 0.0012
354 LEUKAEMIA RECURRENT 2 0.0012
355 ACUTE KIDNEY INJURY 178 0.0012
356 RETINITIS 2 0.0012
357 PRODUCT PACKAGING DIFFICULT TO OPEN 3 0.0011
358 LEUKOPENIA 57 0.0011
359 GASTROINTESTINAL OEDEMA 2 0.0011
360 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 2 0.0011
361 LUNG TRANSPLANT 4 0.0011
362 ANAEMIA OF CHRONIC DISEASE 1 0.0011
363 ESCHERICHIA INFECTION 9 0.0011
364 ENTERITIS 7 0.0011
365 DISEASE COMPLICATION 5 0.0011
366 SINUS NODE DYSFUNCTION 2 0.0011
367 RASH MORBILLIFORM 3 0.0011
368 BIOPSY 1 0.0011
369 NECROSIS 6 0.0011
370 BLOOD UREA ABNORMAL 1 0.0011
371 STATUS EPILEPTICUS 12 0.0011
372 HYPERBILIRUBINAEMIA 11 0.0011
373 RESPIRATORY SYMPTOM 3 0.0011
374 PNEUMATOSIS INTESTINALIS 3 0.0011
375 DRUG DISPENSED TO WRONG PATIENT 1 0.0010
376 DRUG INTERACTION 166 0.0010
377 DEVICE RELATED THROMBOSIS 1 0.0010
378 PRODUCT PRESCRIBING ISSUE 22 0.0010
379 DEVICE RELATED SEPSIS 2 0.0010
380 ENCEPHALOPATHY 24 0.0010
381 PRODUCT DISTRIBUTION ISSUE 9 0.0010
382 CAPILLARY LEAK SYNDROME 2 0.0010
383 ORAL DISORDER 7 0.0010
384 STAPHYLOCOCCUS TEST POSITIVE 2 0.0009
385 BLOOD SODIUM ABNORMAL 1 0.0009
386 PNEUMONIA VIRAL 3 0.0009
387 VIROLOGIC FAILURE 5 0.0009
388 GINGIVITIS 5 0.0009
389 HAEMODYNAMIC INSTABILITY 7 0.0009
390 AGRANULOCYTOSIS 17 0.0009
391 INFECTION SUSCEPTIBILITY INCREASED 2 0.0009
392 ABDOMINAL ABSCESS 4 0.0009
393 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 8 0.0009
394 CHOLESTATIC LIVER INJURY 2 0.0009
395 POTENTIATING DRUG INTERACTION 3 0.0009
396 CHRONIC GASTRITIS 2 0.0009
397 SUSPECTED OFF LABEL USE 4 0.0009
398 ACUTE RESPIRATORY FAILURE 17 0.0009
399 DISTRIBUTIVE SHOCK 2 0.0009
400 ALTERED STATE OF CONSCIOUSNESS 19 0.0009
401 PNEUMONIA BACTERIAL 8 0.0009
402 HEPATIC FAILURE 26 0.0009
403 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 2 0.0009
404 LEUKAEMIA 8 0.0008
405 CYTOKINE RELEASE SYNDROME 17 0.0008
406 PANCREATITIS ACUTE 19 0.0008
407 BONE MARROW TOXICITY 1 0.0008
408 PLATELET COUNT ABNORMAL 5 0.0008
409 CLOSTRIDIUM COLITIS 1 0.0008
410 OFF LABEL USE 718 0.0008
411 RENAL TUBULAR NECROSIS 8 0.0008
412 BLOOD ELECTROLYTES ABNORMAL 1 0.0008
413 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 2 0.0008
414 IMMUNODEFICIENCY 12 0.0008
415 MALNUTRITION 9 0.0008
416 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 1 0.0008
417 TOXIC ENCEPHALOPATHY 4 0.0008
418 BRONCHIAL SECRETION RETENTION 1 0.0008
419 HEPATIC CYTOLYSIS 10 0.0008
420 CEREBRAL ISCHAEMIA 4 0.0008
421 ELECTROLYTE IMBALANCE 9 0.0008
422 BILIARY OBSTRUCTION 1 0.0008
423 VENTRICULAR DYSFUNCTION 2 0.0008
424 ABDOMINAL OPERATION 1 0.0008
425 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 2 0.0008
426 SERUM FERRITIN INCREASED 4 0.0008
427 BLOOD PHOSPHORUS INCREASED 2 0.0007
428 HYPERURICAEMIA 3 0.0007
429 CENTRAL NERVOUS SYSTEM LYMPHOMA 1 0.0007
430 ENCEPHALITIS 5 0.0007
431 CYSTIC FIBROSIS 4 0.0007
432 STREPTOCOCCAL INFECTION 4 0.0007
433 ENDOTRACHEAL INTUBATION 2 0.0007
434 INTESTINAL PERFORATION 8 0.0007
435 BRONCHIAL OBSTRUCTION 1 0.0007
436 PSYCHOMOTOR RETARDATION 2 0.0007
437 ACUTE LYMPHOCYTIC LEUKAEMIA 2 0.0007
438 POOR PERIPHERAL CIRCULATION 3 0.0007
439 HEART VALVE INCOMPETENCE 2 0.0007
440 PNEUMONITIS 19 0.0007
441 ENTEROCOLITIS 4 0.0007
442 STAPHYLOCOCCAL BACTERAEMIA 3 0.0007
443 FUNGAL INFECTION 23 0.0007
444 RESPIRATORY SYNCYTIAL VIRUS INFECTION 6 0.0007
445 HYPOCALCAEMIA 13 0.0007
446 HYPOVOLAEMIA 4 0.0007
447 LYMPHOPROLIFERATIVE DISORDER 2 0.0007
448 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 4 0.0007
449 BLOOD PARATHYROID HORMONE DECREASED 1 0.0007
450 PRODUCT USE IN UNAPPROVED INDICATION 165 0.0007
451 MOUTH ULCERATION 14 0.0007
452 FULL BLOOD COUNT ABNORMAL 7 0.0007
453 VASCULAR DEVICE INFECTION 3 0.0007
454 DIASTOLIC DYSFUNCTION 2 0.0006
455 OLIGURIA 4 0.0006
456 HOSPITALISATION 99 0.0006
457 WOUND INFECTION 7 0.0006
458 RED BLOOD CELL COUNT DECREASED 18 0.0006
459 GINGIVAL PAIN 5 0.0006
460 PRODUCT AVAILABILITY ISSUE 14 0.0006
461 SHOCK HAEMORRHAGIC 5 0.0006
462 LYMPHOCYTE COUNT INCREASED 2 0.0006
463 TOOTH INFECTION 8 0.0006
464 INABILITY TO AFFORD MEDICATION 6 0.0006
465 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
466 COVID-19 PNEUMONIA 7 0.0006
467 BONE MARROW FAILURE 12 0.0006
468 BACTERIAL INFECTION 11 0.0006
469 MATERNAL EXPOSURE BEFORE PREGNANCY 4 0.0006
470 TRANSAMINASES INCREASED 13 0.0006
471 APLASIA PURE RED CELL 2 0.0006
472 NEUTROPENIA 79 0.0006
473 BLOOD CREATININE ABNORMAL 2 0.0006
474 MALABSORPTION 3 0.0006
475 URINE OUTPUT DECREASED 5 0.0006
476 GLOMERULAR FILTRATION RATE DECREASED 7 0.0006
477 BRONCHIOLITIS 2 0.0006
478 PULMONARY TOXICITY 4 0.0006
479 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 31 0.0006
480 PERICARDIAL EFFUSION 13 0.0006
481 THROMBOCYTOPENIA 62 0.0006
482 MYELODYSPLASTIC SYNDROME 8 0.0006
483 CLOSTRIDIUM DIFFICILE INFECTION 12 0.0005
484 FULL BLOOD COUNT DECREASED 11 0.0005
485 UROSEPSIS 5 0.0005
486 CARDIAC DYSFUNCTION 2 0.0005
487 PULMONARY ALVEOLAR HAEMORRHAGE 3 0.0005
488 BLOOD IRON INCREASED 1 0.0005
489 CHOLECYSTITIS ACUTE 3 0.0005
490 HERPES VIRUS INFECTION 3 0.0005
491 HYPERCHOLESTEROLAEMIA 5 0.0005
492 HYPERTRIGLYCERIDAEMIA 3 0.0005
493 PULMONARY HAEMORRHAGE 4 0.0005
494 APLASIA 1 0.0005
495 BICYTOPENIA 1 0.0005
496 TORSADE DE POINTES 4 0.0005
497 DECREASED IMMUNE RESPONSIVENESS 5 0.0005
498 HOSPICE CARE 5 0.0005
499 COLITIS 19 0.0005
500 MELAENA 11 0.0005
501 INTRACRANIAL ANEURYSM 2 0.0005
502 PLATELET COUNT DECREASED 53 0.0005
503 TREATMENT FAILURE 41 0.0005
504 PRODUCT ADMINISTRATION ERROR 10 0.0005
505 MUSCLE DISORDER 4 0.0005
506 RED CELL DISTRIBUTION WIDTH INCREASED 2 0.0005
507 NO ADVERSE EVENT 87 0.0005
508 RENAL IMPAIRMENT 40 0.0005
509 DEVICE CONNECTION ISSUE 1 0.0005
510 MUSCLE ATROPHY 6 0.0005
511 WHITE BLOOD CELL COUNT ABNORMAL 3 0.0005
512 ANAEMIA MACROCYTIC 1 0.0005
513 CATHETER SITE ERYTHEMA 1 0.0005
514 HAEMOPTYSIS 13 0.0005
515 INCORRECT PRODUCT ADMINISTRATION DURATION 10 0.0005
516 INSURANCE ISSUE 7 0.0005
517 NEUROTOXICITY 8 0.0005
518 MELANOCYTIC NAEVUS 2 0.0005
519 CORONAVIRUS INFECTION 3 0.0005
520 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 1 0.0005
521 CLOSTRIDIUM TEST POSITIVE 1 0.0005
522 RENAL FAILURE 60 0.0005
523 OBSTRUCTIVE AIRWAYS DISORDER 5 0.0004
524 MENINGITIS 3 0.0004
525 CARDIOTOXICITY 4 0.0004
526 SKIN INFECTION 5 0.0004
527 MENINGITIS ASEPTIC 2 0.0004
528 REBOUND EFFECT 5 0.0004
529 CYSTITIS 14 0.0004
530 DRUG LEVEL ABOVE THERAPEUTIC 2 0.0004
531 LACTIC ACIDOSIS 14 0.0004
532 LARGE INTESTINE PERFORATION 3 0.0004
533 HYPOMAGNESAEMIA 6 0.0004
534 SKIN ABRASION 2 0.0004
535 SEPSIS 47 0.0004
536 HAEMATOTOXICITY 4 0.0004
537 VIRAL UPPER RESPIRATORY TRACT INFECTION 2 0.0004
538 LIVER FUNCTION TEST INCREASED 9 0.0004
539 DERMATITIS BULLOUS 3 0.0004
540 HYPOKALAEMIA 19 0.0004
541 RESPIRATORY FAILURE 30 0.0004
542 MAJOR DEPRESSION 3 0.0004
543 MOUTH HAEMORRHAGE 3 0.0004
544 INCORRECT DOSAGE ADMINISTERED 2 0.0004
545 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 7 0.0004
546 DYSURIA 15 0.0004
547 HYPERVOLAEMIA 2 0.0004
548 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
549 ORGANISING PNEUMONIA 2 0.0004
550 DEVICE INFUSION ISSUE 1 0.0004
551 CATHETER SITE HAEMORRHAGE 1 0.0004
552 HYPOXIA 14 0.0004
553 TASTE DISORDER 8 0.0004
554 ENDODONTIC PROCEDURE 1 0.0004
555 APPENDICITIS PERFORATED 1 0.0004
556 SUBARACHNOID HAEMORRHAGE 4 0.0004
557 NEUTROPHIL COUNT DECREASED 16 0.0004
558 ABDOMINAL INFECTION 1 0.0004
559 CANCER PAIN 1 0.0004
560 DIFFUSE LARGE B-CELL LYMPHOMA 3 0.0004
561 CATHETER SITE PAIN 1 0.0004
562 ACTINIC KERATOSIS 1 0.0004
563 DRUG-INDUCED LIVER INJURY 12 0.0004
564 BLOOD LACTATE DEHYDROGENASE INCREASED 6 0.0004
565 ANIMAL BITE 1 0.0004
566 BLOOD SODIUM INCREASED 1 0.0004
567 HYPERKALAEMIA 13 0.0004
568 ADVERSE EVENT 34 0.0004
569 NONSPECIFIC REACTION 2 0.0004
570 STAPHYLOCOCCAL INFECTION 12 0.0004
571 DEAFNESS UNILATERAL 2 0.0004
572 GENERALISED TONIC-CLONIC SEIZURE 6 0.0004
573 ORAL PAIN 8 0.0004
574 ANAL HAEMORRHAGE 1 0.0004
575 FACE OEDEMA 6 0.0004
576 CANDIDA INFECTION 6 0.0004
577 HAEMATEMESIS 9 0.0004
578 DIALYSIS 5 0.0004
579 DUODENAL ULCER HAEMORRHAGE 1 0.0003
580 MYOCARDITIS 4 0.0003
581 ANURIA 3 0.0003
582 BLOOD URIC ACID INCREASED 2 0.0003
583 STOMATITIS 21 0.0003
584 PRODUCT USE ISSUE 65 0.0003
585 BILIARY COLIC 1 0.0003
586 LUNG INFILTRATION 3 0.0003
587 PRODUCT DOSE OMISSION ISSUE 98 0.0003
588 CENTRAL VENOUS CATHETERISATION 1 0.0003
589 VIRAL INFECTION 11 0.0003
590 EMERGENCY CARE 1 0.0003
591 EATING DISORDER 7 0.0003
592 WHITE BLOOD CELL COUNT DECREASED 35 0.0003
593 COGNITIVE DISORDER 15 0.0003
594 HYPOPHAGIA 8 0.0003
595 PROCTALGIA 2 0.0003
596 HAEMOGLOBIN ABNORMAL 2 0.0003
597 ORAL HERPES 6 0.0003
598 INFLAMMATORY BOWEL DISEASE 3 0.0003
599 THERAPY CHANGE 3 0.0003
600 IMMUNE SYSTEM DISORDER 4 0.0003
601 TERMINAL STATE 2 0.0003
602 ATRIAL FIBRILLATION 29 0.0003
603 INFECTION 43 0.0003
604 BLOOD BILIRUBIN INCREASED 8 0.0003
605 TACHYPNOEA 4 0.0003
606 LIVER DISORDER 13 0.0003
607 ACUTE HEPATIC FAILURE 4 0.0003
608 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3 0.0003
609 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
610 ECCHYMOSIS 2 0.0003
611 HAEMATOCHEZIA 16 0.0003
612 HYPERTRANSAMINASAEMIA 2 0.0003
613 PETECHIAE 3 0.0003
614 PYREXIA 99 0.0003
615 HALLUCINATION, VISUAL 6 0.0003
616 LYMPHOCYTE COUNT DECREASED 5 0.0003
617 PRODUCT SUPPLY ISSUE 2 0.0003
618 OEDEMA 15 0.0003
619 BLOOD CREATININE INCREASED 18 0.0003
620 PULMONARY THROMBOSIS 3 0.0003
621 BLOOD GLUCOSE ABNORMAL 5 0.0003
622 COVID-19 47 0.0003
623 CATHETER SITE INFECTION 1 0.0003
624 COMMUNICATION DISORDER 1 0.0003
625 PROCEDURAL COMPLICATION 2 0.0003
626 POST PROCEDURAL COMPLICATION 5 0.0003
627 DEVICE RELATED INFECTION 4 0.0003
628 FOOD ALLERGY 2 0.0003
629 CELLULITIS 13 0.0003
630 CARDIOPULMONARY FAILURE 1 0.0003
631 PLASMA CELL MYELOMA 10 0.0003
632 GASTROINTESTINAL INFLAMMATION 2 0.0003
633 GASTROINTESTINAL HAEMORRHAGE 21 0.0003
634 AZOTAEMIA 1 0.0003
635 BLEPHARITIS 1 0.0002
636 INTERSTITIAL LUNG DISEASE 12 0.0002
637 HYPOGLYCAEMIA 12 0.0002
638 PRODUCT DOSE OMISSION 16 0.0002
639 ILEUS 3 0.0002
640 EMBOLISM 2 0.0002
641 HEMIPLEGIA 2 0.0002
642 EOSINOPHIL COUNT INCREASED 2 0.0002
643 INTENTIONAL PRODUCT USE ISSUE 21 0.0002
644 CARDIAC FAILURE CHRONIC 1 0.0002
645 FACIAL PARALYSIS 2 0.0002
646 BLOOD MAGNESIUM DECREASED 2 0.0002
647 PNEUMONIA 75 0.0002
648 PYELONEPHRITIS 2 0.0002
649 DIVERTICULUM INTESTINAL 1 0.0002
650 DEATH 196 0.0002
651 CONDITION AGGRAVATED 69 0.0002
652 HEPATOTOXICITY 5 0.0002
653 INFLUENZA 25 0.0002
654 DRUG INEFFECTIVE 295 0.0002
655 GASTROINTESTINAL INFECTION 2 0.0002
656 LOSS OF LIBIDO 2 0.0002
657 ANAEMIA 42 0.0002
658 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
659 DISEASE PROGRESSION 26 0.0002
660 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
661 CHRONIC MYELOID LEUKAEMIA 1 0.0002
662 CARDIO-RESPIRATORY ARREST 9 0.0002
663 APHONIA 3 0.0002
664 HEPATIC FUNCTION ABNORMAL 8 0.0002
665 APPENDICITIS 2 0.0002
666 PLEURAL EFFUSION 13 0.0002
667 CARDIAC TAMPONADE 1 0.0002
668 PROTEINURIA 4 0.0002
669 THERAPY INTERRUPTED 15 0.0002
670 IMPAIRED QUALITY OF LIFE 3 0.0002
671 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 7 0.0002
672 CARDIAC ARREST 17 0.0002
673 BREATH SOUNDS ABNORMAL 1 0.0002
674 HAEMATOCRIT DECREASED 4 0.0002
675 ABDOMINAL TENDERNESS 1 0.0002
676 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
677 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
678 HYPONATRAEMIA 11 0.0002
679 THERAPY CESSATION 10 0.0002
680 VENTRICULAR EXTRASYSTOLES 2 0.0002
681 THERAPY PARTIAL RESPONDER 3 0.0002
682 FOLLICULITIS 2 0.0002
683 CATATONIA 1 0.0002
684 PRODUCT USE COMPLAINT 3 0.0002
685 BLOOD LACTIC ACID INCREASED 1 0.0002
686 POOR QUALITY PRODUCT ADMINISTERED 2 0.0002
687 ASPARTATE AMINOTRANSFERASE INCREASED 10 0.0002
688 ANAL FISTULA 1 0.0002
689 COMPRESSION FRACTURE 1 0.0002
690 SINUSITIS 19 0.0002
691 CHEILITIS 1 0.0002
692 SKIN LACERATION 2 0.0002
693 DIVERTICULITIS 5 0.0002
694 ALANINE AMINOTRANSFERASE INCREASED 11 0.0002
695 DYSPHAGIA 17 0.0002
696 ANGIOPATHY 1 0.0002
697 ACUTE PULMONARY OEDEMA 1 0.0002
698 THERAPY NON-RESPONDER 8 0.0002
699 TOXICITY TO VARIOUS AGENTS 30 0.0002
700 MITRAL VALVE INCOMPETENCE 2 0.0002
701 INTERNAL HAEMORRHAGE 2 0.0002
702 CARDIAC VALVE DISEASE 1 0.0002
703 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
704 LABORATORY TEST ABNORMAL 5 0.0002
705 DRUG ERUPTION 3 0.0002
706 DISEASE RECURRENCE 8 0.0002
707 ACCIDENT 2 0.0002
708 GASTROENTERITIS VIRAL 3 0.0002
709 HAEMOGLOBIN DECREASED 17 0.0002
710 NEURALGIA 4 0.0002
711 DERMATITIS ACNEIFORM 1 0.0002
712 ABDOMINAL PAIN 38 0.0002
713 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 33 0.0002
714 PNEUMONIA ASPIRATION 4 0.0002
715 BRAIN OEDEMA 2 0.0002
716 MYDRIASIS 2 0.0002
717 CARDIAC FLUTTER 1 0.0002
718 HAEMATOMA 4 0.0002
719 DRUG SPECIFIC ANTIBODY PRESENT 1 0.0002
720 RESPIRATORY TRACT INFECTION 4 0.0002
721 VISUAL IMPAIRMENT 19 0.0002
722 BEDRIDDEN 2 0.0002
723 GASTRITIS 4 0.0002
724 UPPER LIMB FRACTURE 3 0.0002
725 PRESCRIBED UNDERDOSE 3 0.0002
726 CARDIAC FAILURE 12 0.0001
727 PRODUCT TASTE ABNORMAL 2 0.0001
728 HEPATIC ENZYME INCREASED 10 0.0001
729 DECREASED APPETITE 34 0.0001
730 HAEMATURIA 5 0.0001
731 GASTROINTESTINAL DISORDER 13 0.0001
732 DIARRHOEA 93 0.0001
733 ORAL DISCOMFORT 2 0.0001
734 BLOOD TEST ABNORMAL 2 0.0001
735 HEPATOCELLULAR INJURY 2 0.0001
736 CEREBRAL HAEMORRHAGE 5 0.0001
737 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
738 FLUID RETENTION 7 0.0001
739 LIVER FUNCTION TEST ABNORMAL 4 0.0001
740 HYPERGLYCAEMIA 5 0.0001
741 UNDERDOSE 10 0.0001
742 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
743 CARDIOMYOPATHY 2 0.0001
744 SKIN HAEMORRHAGE 2 0.0001
745 RASH MACULO-PAPULAR 3 0.0001
746 PULMONARY OEDEMA 6 0.0001
747 LYMPHOMA 2 0.0001
748 RENAL DISORDER 6 0.0001
749 NERVOUS SYSTEM DISORDER 4 0.0001
750 BRAIN FOG 2 0.0001
751 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 9 0.0001
752 PNEUMOTHORAX 2 0.0001
753 PRODUCT PRESCRIBING ERROR 3 0.0001
754 RESPIRATORY TRACT CONGESTION 2 0.0001
755 PRODUCTIVE COUGH 6 0.0001
756 SCIATICA 2 0.0001
757 ABSCESS 2 0.0001
758 BLOOD DISORDER 1 0.0001
759 DEEP VEIN THROMBOSIS 8 0.0001
760 LIVER INJURY 3 0.0001
761 ABNORMAL FAECES 1 0.0001
762 IMPAIRED HEALING 4 0.0001
763 COAGULOPATHY 2 0.0001
764 BONE PAIN 7 0.0001
765 BLOOD UREA INCREASED 2 0.0001
766 EYE PRURITUS 4 0.0001
767 SKIN EXFOLIATION 10 0.0001
768 ERECTILE DYSFUNCTION 3 0.0001
769 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 21 0.0001
770 UNRESPONSIVE TO STIMULI 3 0.0001
771 OEDEMA PERIPHERAL 14 0.0001
772 MUSCULAR WEAKNESS 13 0.0001
773 JOINT STIFFNESS 3 0.0001
774 BRADYCARDIA 6 0.0001
775 EAR INFECTION 3 0.0001
776 GENERAL PHYSICAL HEALTH DETERIORATION 13 0.0001
777 CONFUSIONAL STATE 18 0.0001
778 SKIN LESION 3 0.0001
779 SKIN DISCOLOURATION 5 0.0001
780 MENTAL STATUS CHANGES 3 0.0001
781 NAUSEA 85 0.0001
782 HEPATIC STEATOSIS 2 0.0001
783 BLOOD SODIUM DECREASED 2 0.0001
784 BLOOD URINE PRESENT 2 0.0001
785 INCORRECT DOSE ADMINISTERED 24 0.0001
786 COMA 5 0.0001
787 DEHYDRATION 14 0.0001
788 PULMONARY FIBROSIS 2 0.0001
789 CHOLESTASIS 2 0.0001
790 ATELECTASIS 1 0.0001
791 ASCITES 3 0.0001
792 KIDNEY INFECTION 2 0.0001
793 RENAL INJURY 3 0.0001
794 SINUS DISORDER 2 0.0001
795 RESPIRATORY DISORDER 3 0.0001
796 DRY EYE 5 0.0001
797 BRAIN INJURY 1 0.0001
798 EMPHYSEMA 1 0.0001
799 THERAPEUTIC RESPONSE DECREASED 6 0.0001
800 ILL-DEFINED DISORDER 6 0.0001
801 FEEDING DISORDER 2 0.0001
802 BODY TEMPERATURE INCREASED 2 0.0001
803 HYPERTENSION 20 0.0001
804 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
805 DYSGEUSIA 7 0.0001
806 NIGHT SWEATS 3 0.0001
807 DECREASED ACTIVITY 1 0.0001
808 CHRONIC KIDNEY DISEASE 7 0.0001
809 VOMITING 43 0.0001
810 TREATMENT NONCOMPLIANCE 5 0.0001
811 FATIGUE 71 0.0001
812 BLOOD PRESSURE DECREASED 6 0.0001
813 DYSPNOEA 51 0.0001
814 URINARY RETENTION 3 0.0001
815 CHROMATURIA 2 0.0001
816 HERPES ZOSTER 5 0.0001
817 SHOCK 2 0.0001
818 SEIZURE 10 0.0001
819 DRY MOUTH 7 0.0001
820 COUGH 24 0.0001
821 DYSPHONIA 5 0.0001
822 CHOLECYSTITIS 1 0.0001
823 GAIT DISTURBANCE 16 0.0001
824 MENTAL IMPAIRMENT 2 0.0001
825 BURSITIS 1 0.0001
826 DRY SKIN 11 0.0001
827 URINARY TRACT INFECTION 14 0.0001
828 ACCIDENTAL OVERDOSE 3 0.0001
829 CEREBRAL INFARCTION 2 0.0001
830 RASH 35 0.0001
831 DYSPNOEA EXERTIONAL 3 0.0001
832 DERMATITIS ALLERGIC 1 0.0001
833 OVERDOSE 17 0.0001
834 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
835 HEPATITIS 2 0.0001
836 DIPLOPIA 2 0.0001
837 PALPITATIONS 9 0.0001
838 DEAFNESS 2 0.0001
839 PANCREATITIS 4 0.0001
840 DYSMENORRHOEA 1 0.0001
841 HYPOTENSION 15 0.0001
842 FREQUENT BOWEL MOVEMENTS 2 0.0001
843 PALLOR 2 0.0001
844 CONSTIPATION 16 0.0001
845 RHABDOMYOLYSIS 3 0.0001
846 COORDINATION ABNORMAL 1 0.0001
847 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
848 FLATULENCE 4 0.0001
849 SYNCOPE 7 0.0001
850 HYPERSOMNIA 2 0.0001
851 CARDIOGENIC SHOCK 1 0.0001
852 ACCIDENTAL UNDERDOSE 1 0.0001
853 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
854 MENTAL DISORDER 3 0.0001
855 INTENTIONAL PRODUCT MISUSE 6 0.0001
856 ACUTE MYOCARDIAL INFARCTION 2 0.0001
857 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
858 COLITIS ULCERATIVE 3 0.0001
859 WEIGHT INCREASED 15 0.0001
860 BLOOD POTASSIUM DECREASED 2 0.0001
861 APHASIA 2 0.0001
862 DIABETES MELLITUS 5 0.0001
863 NEPHROLITHIASIS 3 0.0001
864 EJECTION FRACTION DECREASED 1 0.0001
865 SWOLLEN TONGUE 2 0.0001
866 NEUROPATHY PERIPHERAL 6 0.0001
867 MOOD SWINGS 2 0.0001
868 HIP FRACTURE 2 0.0001
869 BACK DISORDER 1 0.0001
870 ASTHENIA 23 0.0001
871 GAIT INABILITY 2 0.0001
872 CHILLS 7 0.0001
873 TYPE 2 DIABETES MELLITUS 2 0.0001
874 CIRCULATORY COLLAPSE 1 0.0001
875 ABDOMINAL PAIN UPPER 12 0.0001
876 INFLAMMATION 3 0.0001
877 HEART RATE DECREASED 2 0.0001
878 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
879 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
880 TACHYCARDIA 5 0.0001
881 C-REACTIVE PROTEIN INCREASED 2 0.0001
882 AGITATION 4 0.0001
883 TREMOR 9 0.0001
884 OROPHARYNGEAL PAIN 5 0.0001
885 CONJUNCTIVITIS 1 0.0001
886 EYE SWELLING 2 0.0001
887 CARDIAC DISORDER 5 0.0001
888 OXYGEN SATURATION DECREASED 3 0.0001
889 ASTHMA 6 0.0001
890 HALLUCINATION 4 0.0001
891 MYALGIA 9 0.0001
892 ACNE 4 0.0001
893 BLOOD PRESSURE INCREASED 8 0.0001
894 LETHARGY 3 0.0001
895 DRUG INTOLERANCE 5 0.0001
896 EAR PAIN 1 0.0001
897 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
898 CHOKING 1 0.0001
899 WHEEZING 3 0.0001
900 DISABILITY 1 0.0001
901 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
902 DISORIENTATION 2 0.0001
903 HEART RATE INCREASED 5 0.0001
904 BLOOD PRESSURE ABNORMAL 1 0.0001
905 WEIGHT DECREASED 14 0.0001
906 ABORTION SPONTANEOUS 2 0.0000
907 THROMBOSIS 4 0.0000
908 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
909 SOMNOLENCE 10 0.0000
910 EXTRA DOSE ADMINISTERED 2 0.0000
911 INSOMNIA 13 0.0000
912 HYPOAESTHESIA 7 0.0000
913 BALANCE DISORDER 4 0.0000
914 VAGINAL HAEMORRHAGE 2 0.0000
915 PERIPHERAL SWELLING 7 0.0000
916 INFUSION RELATED REACTION 3 0.0000
917 NEOPLASM MALIGNANT 3 0.0000
918 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
919 CHEST PAIN 8 0.0000
920 HEADACHE 27 0.0000
921 OCULAR HYPERAEMIA 2 0.0000
922 PULMONARY EMBOLISM 4 0.0000
923 ABDOMINAL DISCOMFORT 7 0.0000
924 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
925 CONTUSION 4 0.0000
926 ARTHRALGIA 17 0.0000
927 ALOPECIA 8 0.0000
928 AGEUSIA 1 0.0000
929 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
930 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
931 ILLNESS 4 0.0000
932 ANAPHYLACTIC SHOCK 1 0.0000
933 ABDOMINAL DISTENSION 4 0.0000
934 HAEMORRHAGE 4 0.0000
935 DEPRESSED MOOD 2 0.0000
936 HYPERSENSITIVITY 7 0.0000
937 FEELING ABNORMAL 9 0.0000
938 MEDICATION ERROR 2 0.0000
939 DEMENTIA 1 0.0000
940 BLISTER 2 0.0000
941 EYE PAIN 2 0.0000
942 ANXIETY 10 0.0000
943 PRODUCT STORAGE ERROR 3 0.0000
944 DYSSTASIA 1 0.0000
945 SURGERY 2 0.0000
946 NASAL CONGESTION 2 0.0000
947 CATARACT 2 0.0000
948 ADVERSE DRUG REACTION 3 0.0000
949 IRRITABILITY 2 0.0000
950 FEELING HOT 2 0.0000
951 NASOPHARYNGITIS 6 0.0000
952 EMOTIONAL DISORDER 1 0.0000
953 DIZZINESS 16 0.0000
954 MIGRAINE 3 0.0000
955 PRURITUS 12 0.0000
956 RHINORRHOEA 2 0.0000
957 SWELLING FACE 2 0.0000
958 CHOLELITHIASIS 1 0.0000
959 FALL 10 0.0000
960 MALAISE 13 0.0000
961 CEREBROVASCULAR ACCIDENT 5 0.0000
962 PAIN 18 0.0000
963 CHEST DISCOMFORT 3 0.0000
964 VISION BLURRED 4 0.0000
965 MEMORY IMPAIRMENT 4 0.0000
966 EPISTAXIS 2 0.0000
967 HOT FLUSH 2 0.0000
968 UNEVALUABLE EVENT 2 0.0000
969 PARAESTHESIA 4 0.0000
970 DYSKINESIA 1 0.0000
971 ERYTHEMA 5 0.0000
972 LOSS OF CONSCIOUSNESS 3 0.0000
973 ANGIOEDEMA 1 0.0000
974 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
975 SWELLING 2 0.0000
976 BLOOD GLUCOSE DECREASED 1 0.0000
977 DYSPEPSIA 2 0.0000
978 ANAPHYLACTIC REACTION 1 0.0000
979 ARTHROPATHY 1 0.0000
980 URTICARIA 3 0.0000
981 DEPRESSION 4 0.0000
982 BLADDER CANCER 1 0.0000
983 JOINT SWELLING 2 0.0000
984 DISCOMFORT 1 0.0000
985 AMNESIA 1 0.0000
986 PAIN IN EXTREMITY 4 0.0000
987 BACK PAIN 3 0.0000
988 CARDIAC FAILURE CONGESTIVE 1 0.0000
989 MUSCLE SPASMS 2 0.0000
990 DRUG DOSE OMISSION 1 0.0000
991 BLOOD GLUCOSE INCREASED 1 0.0000